切换至 "中华医学电子期刊资源库"

中华神经创伤外科电子杂志 ›› 2016, Vol. 02 ›› Issue (01) : 1 -4. doi: 10.3877/cma.j.issn.2095-9141.2016.01.001

所属专题: 文献

述评

神经生长因子的神经损伤修复机制及作用
徐如祥1,()   
  1. 1. 100700 北京,北京军区总医院附属八一脑科医院
  • 收稿日期:2016-02-14 出版日期:2016-02-15
  • 通信作者: 徐如祥

Mechanisms and effects of nerve growth factor on neural injury and rehabilitation

Ruxing Xu1()   

  • Received:2016-02-14 Published:2016-02-15
  • Corresponding author: Ruxing Xu
引用本文:

徐如祥. 神经生长因子的神经损伤修复机制及作用[J]. 中华神经创伤外科电子杂志, 2016, 02(01): 1-4.

Ruxing Xu. Mechanisms and effects of nerve growth factor on neural injury and rehabilitation[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2016, 02(01): 1-4.

图1 NGF立体构象示意图
图2 NGF受体示意图
图3 NGF受体的信号通路调控机制
[1]
付小兵.脑损伤后认知障碍及神经生长因子的脑保护作用[J].中华神经创伤外科电子杂志, 2015, 1(3): 1-3.
[2]
周志文.测定神经生长因子含量的方法[P]:中国, CN1982891, 2007-06-20.
[3]
Wiesmann C,De Vos AM. Nerve growth factor: structure and function[J]. Cell Mol Life Sci, 2001, 58(5-6): 748-759.
[4]
Campenot RB. NGF and the local control of nerve terminal growth[J]. J Neurobiol, 1994, 25(6): 599-611.
[5]
Zhang Y,Moheban DB,Conway BR, et al. Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation[J]. J Neurosci, 2000, 20(15): 5671-5678.
[6]
Watson FL,Heerssen HM,Bhattacharyya A, et al. Neurotrophins use the Erk5 pathway to mediate a retrograde survival response[J]. Nat Neurosci, 2001, 4(10): 981-988.
[7]
Ginty DD,Segal RA. Retrograde neurotrophin signaling: Trk-ing along the axon[J]. Curr Opin Neurobiol, 2002, 12(3): 268-274.
[8]
Harrington AW,Ginty DD. Long-distance retrograde neurotrophic factor signalling in neurons[J]. Nat Rev Neurosci, 2013, 14(3): 177-187.
[9]
Sofroniew MV,Howe CL,Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair[J]. Annu Rev Neurosci, 2001, 24(1): 1217-1281.
[10]
Holgado-Madruga M,Moscatello DK,Emlet DR, et al. Grb2 Associated Binder1 Mediates Phosphatidylinositol 3Kinase Activation and the Promotion of Cell Survival by Nerve Growth Factor[J]. Proc Nati Acad Sci USA, 1997, 94(23): 12419-12424.
[11]
Yuan J,Yankner BA. Apoptosis in the nervous system[J]. Nature, 2000, 407(6805): 802-809.
[12]
Patapoutian A,Reichardt LF. Trk receptors: mediators of neurotrophin action[J]. Curr Opin Neurobiol, 2001, 11(3): 272-280.
[13]
Moubarak RS,Solé C,Pascual M, et al. The death receptor antagonist FLIP-L interacts with Trk and is necessary for neurite outgrowth induced by neurotrophins[J]. J Neurosci, 2010, 30(17): 6094-6105.
[14]
Kristiansen M,Ham J. Programmed cell death during neuronal development: the sympathetic neuron model[J]. Cell Death Differ, 2014, 21(7): 1025-1035.
[15]
Huang EJ,Reichardt LF. Trk receptors: roles in neuronal signal transduction[J]. Annu Rev Biochem, 2003, 72: 609-642.
[16]
Li Z,Talebian A,Meakin SO. The signaling adapter, FRS2, facilitates neuronal branching in primary cortical neurons via both Grb2-and Shp2-dependent mechanisms[J]. J Mol Neurosci, 2015, 55(3): 663-677.
[17]
Zweifel LS,Kuruvilla R,Ginty DD. Functions and mechanisms of retrograde neurotrophin signalling[J]. Nat Rev Neurosci, 2005, 6(8): 615-625.
[18]
Soline Estrach,Susanne Schmidt,Sylvie Diriong, et al. The Human Rho-GEF trio and its target GTPase RhoG are involved in the NGF pathway, leading to neurite outgrowth[J]. Curr Biol, 2002, 12(4): 307-312.
[19]
Pollack SJ,Harper SJ. Trk neurotrophin receptor activators[J]. Drug News Perspect, 2002, 15(5): 268-277.
[20]
Biswas SC,Greene LA. Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3(BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation[J]. J Biol Chem, 2002, 277(51): 49511-49516.
[21]
Pérez-Navarro E,Alberch J. Protective role of nerve growth factor against excitatory amino acid injury during neostriatal cholinergic neurons postnatal development[J]. Exp Neurol, 1995, 135(2): 146-152.
[22]
Thippeswamy T,Morris R. Nerve growth factor inhibits the expression of nitric oxide synthase in neurones in dissociated cultures of rat dorsal root ganglia[J]. Neurosci Lett, 1997, 230(1): 9-12.
[23]
Lam HH,Bhardwaj A,O′Connell MT, et al. Nerve growth factor rapidly suppresses basal, NMDA-evoked, and AMPA-evoked nitric oxide synthase activity in rat hippocampus in vivo[J]. Proc Nati Acad Sci U S A, 1998, 95(18): 10926-10931.
[24]
Huang F,Liu Z,Liu H, et al. GM1 and NGF modulate Ca2+ homeostasis and GAP43 mRNA expression in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate[J]. Nutr Neurosci, 2007, 10(3-4): 105-111.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 刘佳璇, 徐兵河. 中国乳腺癌临床研究年度进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 259-265.
[3] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[4] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[5] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[6] 曹长青, 郭新艳, 高源, 张存, 唐海利, 樊东, 杨小军, 张松, 赵华栋. 肿瘤微环境参与介导HER2阳性乳腺癌曲妥珠单抗耐药的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 90-95.
[7] 陈珊, 胡智强, 张月明, 唐定, 黎蒙, 赵帅. Orai1、Orai3在乳腺癌组织中的表达及与病理学指标的相关性分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 514-517.
[8] 陈瑜, 尤良顺, 孟海涛, 杨敏. 嵌合抗原受体T细胞治疗多发性骨髓瘤新进展[J]. 中华移植杂志(电子版), 2023, 17(05): 313-320.
[9] 张圣平, 邓琼, 张颖, 张建文, 梁辉, 王铸. 孤儿核受体HNF4α在肾透明细胞癌中的表达及意义[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 627-632.
[10] 吴寅, 陈智琴, 高勇, 权明. Her-2阳性结直肠癌的诊治进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 420-425.
[11] 范博洋, 王宁, 张骞, 王贵玉. 结直肠癌转移调控的环状RNA分子机制研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 426-430.
[12] 王淑友, 宋晓晶, 贾术永, 王广军, 张维波. 肝脏去唾液酸糖蛋白受体靶向活体荧光成像评估酒精性肝损伤肝脏功能的研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 443-446.
[13] 曹旬旬, 费素娟. 食管癌患者肿瘤组织CXCL5和CXCR2的表达与病情和预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 299-304.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要